Related Experiment Videos
Fibrin glue in pulmonary resection: a prospective, randomized, blinded study
Thomas Fabian1, John A Federico, Ronald B Ponn
1Department of Surgery, The Hospital of St. Raphael, New Haven, Connecticut, USA.
The Annals of Thoracic Surgery
|May 9, 2003
Summary
Aerosolized fibrin glue significantly reduces alveolar air leaks (AAL) after lung surgery, decreasing their incidence and duration. This safe and effective treatment offers a promising solution for managing common postoperative complications.
Area of Science:
- Thoracic Surgery
- Surgical Innovation
- Pulmonary Medicine
Background:
- Alveolar air leaks (AAL) are common after lung resection, increasing hospital stay and morbidity.
- Previous studies showed topical fibrin glue lacked efficacy for reducing AAL.
- This study reevaluated fibrin glue's effectiveness in routine pulmonary resections.
Purpose of the Study:
- To assess the efficacy and safety of aerosolized fibrin glue in reducing alveolar air leaks (AAL) post-lung resection.
- To determine the impact of fibrin glue on the incidence and duration of AAL and prolonged AAL (PAAL).
Main Methods:
- 100 patients undergoing lung resection were randomized into two groups: control (no intervention) and experimental (5 mL aerosolized fibrin glue).
- Outcomes including AAL incidence, duration, prolonged AAL (PAAL), chest tube drainage, time to tube removal, and length of stay (LOS) were recorded by a blinded observer.
- Fibrin glue was applied using a pressurized, aerosolized spraying mechanism post-resection.
Main Results:
- The fibrin glue group showed significantly lower AAL incidence (34% vs. 68%, p=0.001) and mean AAL duration (1.1 vs. 3.1 days, p=0.005).
- A significant reduction in prolonged AAL (PAAL) incidence was observed (2% vs. 16%, p=0.015) in the fibrin glue group.
- Mean chest tube removal time decreased (3.5 vs. 5.0 days, p=0.02) with no significant difference in drainage volume or length of stay (LOS).
Conclusions:
- Aerosolized fibrin glue is a safe and effective method for reducing alveolar air leaks (AAL) after lung surgery.
- The treatment halved the overall AAL incidence and markedly reduced PAAL.
- Further research is needed to define optimal use, compare methods, and assess cost-effectiveness.